PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link BE1410, Gadong, Bandar Seri Begawan, Brunei Darussalam.
Epidemiology and Biostatistics, Department of Environmental and Occupational Health, School of Public Health, University of Nevada, Las Vegas, Las Vegas, NV, 89119, USA.
BMC Public Health. 2020 Mar 18;20(1):352. doi: 10.1186/s12889-020-8419-0.
There is a global commitment to eliminating tuberculosis (TB). It is critical to detect and treat cases of latent TB infection (LTBI), the reservoir of new TB cases. Our study assesses trends in publication of LTBI-related research.
We used the keywords ("latent tuberculosis" OR "LTBI" OR "latent TB") to search the Web of Science for LTBI-related articles published 1995-2018, then classified the results into three research areas: laboratory sciences, clinical research, and public health. We calculated the proportions of LTBI-related articles in each area to three areas combined, the average rates of LTBI-related to all scientific and TB-related articles, and the average annual percent changes (AAPC) in rates for all countries and for the top 13 countries individually and combined publishing LTBI research.
The proportion of LTBI-related articles increased over time in all research areas, with the highest AAPC in laboratory (38.2%/yr), followed by public health (22.9%/yr) and clinical (15.1%/yr). South Africa (rate ratio [RR] = 8.28, 95% CI 5.68 to 12.08) and India (RR = 2.53, 95% CI 1.74 to 3.69) had higher RRs of overall TB-related articles to all articles, but did not outperform the average of the top 13 countries in the RRs of LTBI-related articles to TB-related articles. Italy (RR = 1.95, 95% CI 1.45 to 2.63), Canada (RR = 1.73, 95% CI 1.28 to 2.34), and Spain (RR = 1.53, 95% CI 1.13 to 2.07) had higher RRs of LTBI-related articles to TB-related articles.
High TB burden countries (TB incidence > 100 per 100,000 population) published more overall TB-related research, whereas low TB burden countries showed greater focus on LTBI. Given the potential benefits, high TB burden countries should consider increasing their emphasis on LTBI-related research.
全球致力于消除结核病(TB)。检测和治疗潜伏性结核感染(LTBI)病例至关重要,因为 LTBI 是新结核病例的蓄水池。我们的研究评估了与 LTBI 相关研究的发表趋势。
我们使用关键词(“潜伏性结核”或“LTBI”或“潜伏性 TB”)在 Web of Science 中搜索 1995 年至 2018 年发表的与 LTBI 相关的文章,然后将结果分为三个研究领域:实验室科学、临床研究和公共卫生。我们计算了每个领域与三个领域结合的 LTBI 相关文章的比例、LTBI 相关文章与所有科学和 TB 相关文章的平均比率以及所有国家和前 13 个国家的 LTBI 研究的平均年百分变化率(AAPC)。
所有研究领域的 LTBI 相关文章的比例随时间推移而增加,实验室的 AAPC 最高(38.2%/年),其次是公共卫生(22.9%/年)和临床(15.1%/年)。南非(率比 [RR] = 8.28,95%CI 5.68 至 12.08)和印度(RR = 2.53,95%CI 1.74 至 3.69)的总体 TB 相关文章与所有文章的 RR 较高,但在 LTBI 相关文章与 TB 相关文章的 RR 方面并未超过前 13 个国家的平均值。意大利(RR = 1.95,95%CI 1.45 至 2.63)、加拿大(RR = 1.73,95%CI 1.28 至 2.34)和西班牙(RR = 1.53,95%CI 1.13 至 2.07)的 LTBI 相关文章与 TB 相关文章的 RR 较高。
高结核负担国家(结核发病率>100/100,000 人)发表了更多的总体 TB 相关研究,而低结核负担国家则更关注 LTBI。鉴于潜在的益处,高结核负担国家应考虑增加对 LTBI 相关研究的重视。